CLINICAL RESPONSE TO CARDIOVASCULAR DISEASE DRUGS: CLINICAL EXOME PANEL (Sec. & CNVs) – 7 genes

LabGenetics

Delivery time

3-4 weeks

Sample

Blood

850,00€

This panel analyzes key genes involved in the metabolism, transport, and effects of drugs used to treat cardiovascular diseases. It evaluates variants in ABCG2, CYP2C19, CYP2C9, CYP2D6, CYP4F2, SLCO1B1, and VKORC1, which determine the response to anticoagulants (acenocoumarol, warfarin), antiplatelet agents (clopidogrel, ticlopidine), beta-blockers (metoprolol, carvedilol), statins (simvastatin, atorvastatin, fluvastatin), and antiarrhythmics (amiodarone, propafenone). The detection of polymorphisms allows for personalized treatment and reduces the risk of adverse events or therapeutic inefficacy.

Other tests

Exome panel analysis of 29 genes - idiopathic pulmonary fibrosis and surfactant protein deficiency

Exome panel analysis of 29 genes - idiopathic pulmonary fibrosis and surfactant protein deficiency

990,00€

511 gene analysis - epilepsy (using exome sequencing)

511 gene analysis - epilepsy (using exome sequencing)

1.495,00€

Exome analysis of AGXT, GRHPR, and HOGA1 genes - primary hyperoxaluria

Exome analysis of AGXT, GRHPR, and HOGA1 genes - primary hyperoxaluria

690,00€